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ABSTRACT 
Serotonin reuptake variation is linked to a functional polymorphism in the promoter region of 
the SLC6A4 gene on chromosome 17. It is plausible that variations in genetically determined 
SLC6A4 activity may modify the risk of alcohol dependence. To determine whether this allele is 
associated with alcohol dependence, the authors conducted a systematic review and a meta-
analysis. Twenty five studies with 8,885 participants were included. The meta-analysis was 
conducted using a random-effects model.  Overall, the results did not support the association 
between alcohol dependence and SLC6A4 promoter polymorphism for the dominant, recessive 
and additive genetic risk models respectively  (ORs = 0.99 [95% CI: 0.83, 1.18], 0.86 [95% CI: 
0.71, 1.03], and 0.88 [95%CI: 0.69, 1.13]).  When effect modification was tested for gender, 
race/ethnicity, presence/absence of a psychiatric disorder, year of publication, and diagnostic 
criteria, none of the factors were significantly associated with alcohol dependence. The findings 
in this meta-analysis suggest that SLC6A4 promoter polymorphism is not associated with 
alcohol dependence. 
 
Key Words:  
5HTTLPR polymorphism; SLC6A4 gene; meta-analysis; alcohol dependence 
 
 
 
 
 3 
 
INTRODUCTION 
 Alcohol dependence is a complex trait, with multigenic etiology influenced by 
environmental and genetic factors where heritability varies between 40% to 60% (Kimura, 
2011; Sander et al., 1997). The process of addiction at the molecular level involves networks in 
which hundreds of genes may be involved. However, only a few functional genes moderating 
vulnerability to alcohol dependence have been identified. Alcohol dependence is characterized 
by obsessive, compulsive and uncontrolled consumption of alcohol associated with behavior of 
maladaptation and emotional disturbance (Grant et al., 2004; Oroszi, 2004).  
 Several studies have demonstrated that the serotonin (5-hydroxytryptamine: 5-HT) 
system is associated with alcohol dependence (Gorwood et al.,2000; Lesch, 2005). 
Consequently, genetic analyses of 5-HT signaling in alcohol dependence have focused on the 
serotonin transporter gene SLC6A4 due to its main role in the adjustment of serotonergic 
neurotransmission (Lesh et al., 1996; Matsushita et al., 2001). Serotonin reuptake variation is 
linked to a 44 base-pair deletion/insertion polymorphism, customarily called 5-HTTLPR, in the 
promoter region of the SLC6A4 gene on chromosome 17q11.1-q12 (Lesh et al., 1996). This 
polymorphism affects serotonergic neurotransmission by reuptake of synaptic serotonin, 
ending neurotransmission (Sander et al., 1997). The short allele is associated with lower 
transcriptional activity, lower serotonin binding and uptake in platelets and lymphoblasts 
compared with the long allele yielding differential expressions of SLC6A4 (Kranzler et al., 2002; 
Matsushita et al., 2001). Evidence suggests that the SLC6A4 promoter polymorphism may play 
an important role in the pathogenesis of alcohol dependence (Dick et al., 2007; Lesch, 2005). 
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Furthermore, the SLC6A4 gene may regulate the duration and amplitude of serotonin response 
to alcohol dependence (Kenna et al., 2012).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 A number of studies and previous reviews have reported an association between 
SLC6A4 promoter polymorphism and alcohol dependence (Choi et al., 2006; Hallikainen et al., 
1999; Hammoumi et al., 1999). In particular, studies showed an increased frequency of the 
homozygous SS genotype in alcohol dependent individuals compared to controls (Hammoumi 
et al., 1999; Lichtermann et al., 2000). However, the genetic effect of the SLC6A4 promoter 
polymorphism was more pronounced in patients with a history of withdrawal syndromes 
including seizures and/or delirium; suicide attempts; and depression (Gokturk et al., 2008; 
Marques, 2006; Preuss, 2001; Sander et al., 1997). 
 Outcomes that were reported in several case-control studies analyzing the risk of the 
SLC6A4 promoter polymorphism with alcohol dependence were inconsistent. Earlier studies 
reported an association with the short allele in alcohol dependent individuals compared with 
non-alcohol dependent controls; others have reported an association with the long allele; 
whereas some studies did not find an association with either allele (Choi et al., 2006; Gokturk et 
al., 2008; Hallikainen et al., 1999; Ishiguro et al., 1999; Kweon, 2005; Matsushita et al., 2001; 
Thompson, 2010).  In addition, several studies have also investigated the association between 
SLC6A4 promoter polymorphism and psychiatric disorders in adults, including both internalizing 
disorders such as depression and anxiety and externalizing disorders such as antisocial 
personality disorder (ASPD), conduct disorder (CD) and attention deficit hyperactivity disorder 
(ADHD). However, results were mixed (Lotrich, 2004; Schinka, 2004).  
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MATERIALS AND METHODS 
Objective 
 The aim of this meta-analysis was to systematically review available evidence from case-
control studies examining the association of the SLC6A4 promoter polymorphism with alcohol 
dependence. 
Inclusion Criteria 
 Studies were selected if they evaluated an association between SLC6A4 promoter 
polymorphism and alcohol dependence and included non-alcohol dependent control groups. 
Studies included were case-control studies, published in peer-reviewed journals, contained 
original and independent data, described or referenced appropriate genotyping methods and 
protocols and published only in the English language. We identified eligible studies by searching 
Medline (National Library of Medicine, Bethesda Maryland), BIOSIS (Thompson Scientific, 
Stanford, Connecticut) and ISI Web of Science databases for those published before November 
1, 2013. The MEDLINE search strategy was organized using Medical Subjects Headings (MeSH), 
as follows: 5-HTTLPR polymorphism, SLC6A4 gene or genetic or genotype or polymorphism or 
allele or haplotype or genes or genetic polymorphism or genotype and alcohol abuse, or 
chronic alcoholic or alcoholism or alcoholic intoxication or alcohol dependence, alcoholism or 
alcohol and dependence or alcohol dependence. The searches in BIOSIS and ISI Web of Science 
were performed using the same strategy but adjusting the search terms to adjust the differing 
structure of the MeSH tree.  
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Data Extraction 
 Two investigators K.V. and J.A. independently extracted data on: study design; 
population characteristics (sample size, country of origin, ethnicity, age, sex) selection of 
diagnostic criteria used to classify participants  as  alcohol dependent group; selection and 
categorization strategy for  the control group; inclusion or exclusion of psychiatric disorders; 
genotyping method; blinding of genotyping; and genotype and allelic frequencies. Reference 
lists of all relevant papers were cross-checked for possible inclusion. Studies were categorized 
based on place of origin and were divided in three categories: a) Asian including China, Japan 
and Korea; b) European including France, Finland, Germany, Croatia, Italy, Poland and Spain; c) 
Hispanic including Mexico.     
Data Analysis 
 The data on the association between SLC6A4 promoter polymorphism and alcohol 
dependence were pooled by means of weighted average to generate summary odds ratios 
using a random-effects model. This way, each study was weighted by the inverse of its variance, 
taking into account within/between-studies variances. Since previous studies found a significant 
effect on both the S and the L alleles with SLC6A4 promoter polymorphism on the risk of 
alcohol dependence, we used the dominant (LL vs. SS + SL), the recessive (LL + LS vs. SS) and 
additive genetic risk models treating the S allele as the risk allele for this meta-analysis. In 
addition, effect modification was analyzed using multivariate meta-regressions with both the 
log effect sizes and corresponding standard errors as outcomes running Monte Carlo 
permutations (Iterations=1000) to reduce chances of type I error (Higgins and Thompson, 
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2004). Factors that were considered included gender, race/ethnicity, presence/absence of a 
psychiatric disorder, year of publication, and diagnostic criteria. Publication and small-studies 
effect biases (studies more likely to be published because of statistical significance or size) were 
evaluated by creating a funnel plot and employing the Egger linear regression test. Sensitivity 
analysis was done by investigating the influence of each study on the pooled estimate to 
identify the ones that exerted a disproportionate impact. All analyses were performed in STATA 
(Version 11; Stata Corporation, College Station, TX, USA) and a P value of <0.05 was considered 
to be statistically significant for the associations between SLC6A4 promoter polymorphism and 
alcohol dependence.  
RESULTS 
Description of Quality of Included Studies  
 We reviewed 971 titles and abstracts and obtained 175 full-text papers. We identified 
25 case-control studies that met inclusion criteria with a total of 8,885 participants. 
Characteristics of included studies are listed numerically and summarized in Table 1. Five 
studies (Edenberg et al., 1998; Lichtermann et al., 2000; Hill et al., 2013, Samochwiec et al., 
2006 and Dick et al., 2007) were not included in the analysis because they used the 
transmission disequilibrium (TDT) and Pedigree Disequilibrium test (PDT) methodology which 
may compromise the ease of comparison to the majority of studies using case-control methods. 
Two other studies (Nelissery et al., 2003 and Philibert et al., 2008) were also excluded because 
of insufficient publicly available data as shown in Figure 1. 
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 All studies reported genotype and/or allelic frequencies except for study 11 which 
reported only allele frequencies. Determination of alcohol dependence was established using 
several diagnostic criteria: the Diagnostic and Statistical Manual of Mental Disorders, Third 
Edition, Revised; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; 
International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; 
Alcohol Use Disorders Identification Test; International Classification of Disease; European 
Addiction Severity Index and Michigan Alcohol Screening Test. Only study 2 used autopsy-
confirmed cases of alcohol-related pathology to identify cases of alcohol dependence.   
Cases were classified as alcohol dependent without psychiatric disorders and alcohol 
dependent with psychiatric disorders. Controls were classified as non-alcohol dependent. The 
majority of studies did not screen for psychiatric disorders in controls (references 2, 3, 4, 5, 6, 7, 
10, 11, 14, 15, 17, 18, 20, 22, 23, and 24 in Table 1). Eleven studies analyzed alcohol 
dependence and psychiatric disorders including, major depression, suicide attempts and 
antisocial personality (references 3, 4, 7, 8, 12, 14, 15, 16, 17, 19, and 23 in Table 1). Matching 
for sex or age was included in studies 7 and 17, while only studies 12, 18, and 23 reported 
blinding of clinical investigators. Finally, statistically significant departures from Hardy-
Weinberg Equilibrium in the controls were detected in studies 1 and 3. 
Association between SLC6A4 promoter polymorphism and alcohol dependence 
 Twenty five studies, including a total of 4388 cases and 4497 controls, reported 
genotype frequencies for SLC6A4 promoter polymorphism and alcohol dependence. For all 
studies combined, when a dominant, recessive or additive model was assumed, non significant 
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associations were found between SLC6A4 promoter polymorphism and alcohol dependence for 
all genetic risk models respectively  (ORs = 0.99 [95% CI: 0.83, 1.18], 0.86 [95% CI: 0.71, 1.03], 
and 0.88 [95%CI: 0.69, 1.13]).  Similar results were found for allele frequency (OR = 0.96, 95 % 
CI: 0.86, 1.07). Significant heterogeneity between studies was observed (Cochran Q test p-value 
< 0.10; I² ranging from 41.3% to 61.8%) as shown in Figures 2-5.  When effect modification was 
tested, none of the factors included in the meta-regression analysis significantly moderated the 
association between SLC6A4 promoter polymorphism and alcohol dependence in any of the 
models (Table 2). There was a subtle asymmetry on visual observation of funnel plots for the 
comparison between the dominant, recessive and additive genetic risk models suggesting 
publication bias. However, the Egger tests for small-studies effect were not significant. When 
the influence analysis test was performed, no study omitted significantly changed the overall 
estimates. 
DISCUSSION 
 This meta-analysis did not find an overall association between SLC6A4 promoter 
polymorphism and alcohol dependence. Substantial variations between studies were observed. 
The observed heterogeneity could be due to a difference in how the samples were selected and 
screened or to methods of genotyping or interaction with other risk factors. We tested whether 
genotype frequencies in the control groups were in agreement with Hardy Weinberg 
equilibrium because a departure from it may point to genotyping errors resulting in misleading 
results. However, exclusion of the two studies with significant deviation from Hardy-Weinberg 
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equilibrium did not account for the heterogeneity nor significantly changed the pooled 
estimates.  
 All of the studies had one or more methodological limitations including: 1) inconsistent 
screening for control groups for alcohol dependence and/or other psychiatric disorders; 2) lack 
of matching for or adequate control group; 3) insufficient description of genotyping methods; 
4) potential disparity in case definition due to the different diagnostic criteria used; and 5) 
ambiguity in the severity of alcohol dependence, including how much alcohol was consumed 
and for how long. Selection of the control groups was especially problematic since many studies 
included convenience samples rather than population-based controls. These factors may have 
led to the observed heterogeneity in our meta-analysis.  
 To further understand the variance that was unaccounted for by SLC6A4 promoter 
polymorphism and alcohol dependence, potential effect modifiers were examined in the meta-
analysis.  However, gender, race/ethnicity, year of publication, presence/absence of psychiatric 
disorders, and diagnostic criteria did not moderate the overall effect. Results from this meta-
analysis differed from Feinn et al (2005), where studies with a co-occurring clinical feature 
moderated the association with alcohol dependence (Feinn, Nellissery,and  Kranzler, 2005). Our 
results may differ because in addition to the four studies from Feinn et al, (Gorwood et al., 
2000; Johann et al., 2003; Sander et al., 1997; and Stoltenberg et al., 2002), we added, Preuss et 
al., 2001; Marques et al., 2006; Matsushita et al., 2001; Ishiguro et al., 1999; and Gokturk et al., 
2008, generating a larger estimate. The heterogeneity of psychiatric disorders in the studies 
 11 
 
may have contributed to the negative results. However, grouping them by psychiatric disorder 
as suggested by Fenn and Colleagues was not possible due to the limited number of studies.  
 Even though considerable efforts were made to locate all studies, certain limitations in 
this meta-analysis should be noted.  First, only published studies were included in the review 
and other potentially eligible, but unpublished studies with either positive or negative effects 
could not be included. Regardless, no publication bias was observed. Second, differences in the 
methodologies used by the selected studies did not permit for a combination of case-control 
and family-based studies. Last, overestimation of the odds ratio cannot be ruled out since the 
modest strength of association found in this study is similar to reported odd ratios by other 
meta-analysis with similar associations.  
 Authors of previous reviews, meta-analyses and primary studies have presented 
contrasting findings on the role of SLC6A4 promoter polymorphism and alcohol dependence.    
A recent meta-analysis by Cao et al. (2013) where case-control and family-based studies were 
evaluated for the association between SLC6A4 promoter polymorphism (5HTTLPR) and alcohol, 
heroin, cocaine and methamphetamine abuse found a significant association with alcohol 
dependence (Cao, 2013). Our meta-analysis excluded family-based studies that used PDT, TDT 
and haplotype relative risk methodologies, which may have been a contributing factor for the 
null finding.  Alternately, a meta-analysis of case-control studies by McHugh et al. (2010), which 
excluded PDT, and TDT methods and assessed publication bias, determined that the year of 
publication and study sample size acted as moderators, making the results non-significant when 
nine unpublished studies with null results were added.(McHugh, 2010) Consistent with the 
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findings from McHugh et al., our research added six studies that were not included in their 
meta-analysis (references 13, 18, 19, 21, 23, and 25 from Table 1), where four of the studies did 
not find an association between SLC6A4 promoter polymorphism and alcohol dependence.  
Alcohol dependence is a complex disorder with multiple subtypes and clinical phenotypes, it 
may be relevant to identify genetic susceptibility variants affecting variability in serotonin 
pathway. This may hold the potential for premorbid risk assessment, preventive strategies and 
treatment individualization for individuals genetically predisposed  to alcohol dependence.     
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Figure 1. Study selection process 
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Figure 2. Forest plot showing the association between 5HTTLPR polymorphism and alcohol 
dependence assuming additive model 
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Figure 3. Forest plot showing the association between 5HTTLPR polymorphism and alcohol 
dependence assuming a dominant (LL vs. SS + SL) model 
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Figure 4. Forest plot showing the association between 5HTTLPR polymorphism and alcohol 
dependence assuming a recessive (LL + LS vs. SS) model 
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Figure 5. Forest plot of association between 5HTTLPR and alcohol dependence, comparing 
allele frequency 
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  Participants characteristics   Genotype Frequencies ORhet 
(95% CI) 
ORhom 
(95% CI) 
ORAdd 
(95% CI) Cases Controls 
  Cases Controls L/L L/S S/S L/L L/S S/S    
1 Choi 
2006 
Korean alcoholic subjects; DSM-IV 
and AUDIT criteria; with and 
without family history of alcohol 
dependence and without major 
mental disorder; males; n = 111; 
mean age 43.5 years 
 
Korean non-alcoholics; without 
major psychological disorders; 
males; n = 123; mean age 45.5 
Familial 10 27 4 55 64 4 2.3 
0.98, 5.84 
5.5 
0.85, 33.9 
2.5 
1.1, 5.6 
Non 
familial 
27 37 4    1.2 
0.61, 2.3 
2.0 
0.35, 11.7 
 
1.2 
0.76, 2.23 
2 Foley  
2004 
Brain tissue from Caucasian 
alcoholics; with alcohol related 
brain damage;  n= 74 
 
Non alcoholic brain tissue; with 
non alcohol related brain 
damage; n= 108 
 24 32 18 34 55 19 1.6 
0.75, 3.54 
1.3 
0.58,  0.78 
1.5 
0.72,  3.1 
3 Gokturk  
2008 
Sweden alcoholic subjects with and 
without anxiety and/or depressive 
disorder; ICD10 criteria; interviewed 
on the history of alcohol abuse and 
psychiatric illness; n = 110; females; 
age range 18-75 
 
Sweden non-alcoholic controls  
from the Survey of Adolescent 
Life in Vestmanland-2006; 
n = 631; females; 
age range 17-18 
With  
Anx /dep 
5 13 4 213 285 133 1.5 
0.44, 4.73 
0.8 
0.25, 2.94 
1.2 
0.43, 3.74 
Without 
anx/dep 
 
40 33 15    1.0 
0.56, 1.94 
1.6 
0.89,  3.16 
1.3 
0.70, 2.36 
4 Gorwood  
2000 
 
 
 
 
 
 
 
 
French alcoholic subjects with 
major depressive disorder, 
antisocial personality disorder, 
pathological gambling, agoraphobia, 
and other addictions; DSM-III-R 
criteria; excluded dementia, 
schizophrenia, bipolar maniac-
depressive disorder; interview;        
n = 110 males; mean age 43.6 
French non-alcoholics without 
any substance dependence; 
n = 61 males; age > 35 years 
old 
With 
suicide 
12 30 13 24 26 11 1.4 
0. 49, 3.08 
1.2 
0.52, 3.59 
1.2 
0.52, 3.28 
Without 
suicide 
21 26 8    0.9 
0.48, 2.74 
0.4 
0.24, 2.79 
0.7 
0.51, 2.33 
5 Hallikainen  
1999 
Finnish alcoholics subjects, type 1 
and type 2; DSM-III-R criteria, MAST 
test; excluded major mental 
disorder; n = 166; 114 type 1, 51 
type 2; mean age 43.8 
 
Finnish non-alcoholic; 
interview and screened for 
alcohol dependence; n = 54 
mean age 44.1 
Type I 
 
50 
 
37 
 
27 
 
26 
 
20 
 
8 
 
0.96 
0.44, 2.1 
1.7 
0.65, 5.10 
1.2 
0.62, 2.35 
Type II 15 18 18    1.6 
0.58, 4.23 
3.9 
1.22, 12.8 
2.3 
0.99, 4.98 
6 Hammoumi  
1999 
French alcoholic subjects; 
depression disorder excluded; 
MAST criteria; interview for alcohol 
French non-alcoholic controls 
from a regional transfusion 
center; n = 38 
 34 43 25 20 14 4 4.2 
0.74, 4.46 
3.7 
1.03, 16.4 
2.2 
1.04, 4.74 
Table 1. Characteristics of included studies 
 2 
 
dependence; n = 104 
 
 
7 Ishiguro  
1999 
 
Japanese alcoholic subjects with 
history of withdrawal or delirium; 
DSM-IV criteria; major psychiatric 
disorder or substance dependence 
other than alcohol or nicotine 
excluded; interviewed on history of 
alcohol abuse; n = 166; 153 men, 
13 women; mean age 52.2 
 
Japanese non-alcoholics 
n = 213 
 16 114 286 201 81 8 0.70 
0.25, 1.84 
0.71 
0.25, 1.80 
1.0 
0.65, 1.67 
8 Johann  
2003 
German alcoholic subjects with and 
without ADHD; DSM-IV , ICD-10 
criteria; major psychiatric disorder 
or substance dependence other 
than alcohol or nicotine excluded;   
n = 314; 262 men, 52 women; mean 
age 43.1 years old 
 
German non-alcoholic without 
addictive or major psychiatric 
disorder; interview; n = 220 
With ADHD 23 34 10 69 116 35 0.88 
0.46, 1.7 
0.86 
0.33, 2.13 
0.87 
0.49, 1.56 
Without 
ADHD 
85 120 42    0.84 
0.55, 1.29 
0.97 
0.54, 1.75 
0.87 
0.59, 1.28 
9 Kohnke  
2006 
 
 
German alcoholic subjects with no 
history or family history of 
psychiatric disorders; DSM-IV 
criteria; n = 215 
German non-alcoholic subjects 
with no history or family 
history or psychiatric disorders 
or addition except for nicotine 
n=94 
 
 75 89 51 35 44 15 1.2 
0.67, 2.06 
4.1 
2.03, 8.16 
1.9 
1.13, 3.21 
10 Konishi  
2004 
 
Mexican American alcoholic 
subjects; DSM-IV criteria; without 
history of psychiatric disorders. n = 
130 males; mean age 38.2 years old 
Mexican American non-
alcoholic;  n = 251; 105 men, 
146 females; mean age 32.5 
years old 
 
 32 90 78 63 112 76 1.6 
0.98, 2.58 
2.1 
1.08, 4.19 
1.8 
1.09, 2.82 
11 Kranzler  
2002 
 
 
European American, African 
American alcoholic subjects; DSM-
III-R criteria; with cocaine and opiod 
dependence;  n = 471, 363 EA, 108 
AA; 353 males, 108 females 
European American, African 
American controls; screened 
for alcohol dependence;  n = 
235, 192 EA, 43 AA; 138 males, 
97 females 
 
 
 
         
12 Kweon  
2004 
 
 
Korean alcoholic subjects; DSM-IV 
criteria; semi-structured interview 
for aggressive behavior; major 
psychiatric disorder or substance 
Korean non-alcoholics; 
interviewed for psychiatric 
conditions or neurological 
disease; family history of 
 
 
29 40 76 6 65 130 1.0 
0.36, 1.75 
8.3 
3.16, 25.2 
1.7 
1.07, 2.47 
 3 
 
 
 
 
dependence other than alcohol or 
nicotine were excluded; 
n = 145 males 
alcoholism or major psychiatric 
or neurological diseases were 
excluded; n = 201 
 
13 Lee  
2009 
Chinese alcoholic subjects; DSM-IV 
criteria; clinical structured interview 
for family alcohol history and 
psychiatric information;  major 
psychiatric disorder or substance 
dependence other than alcohol or 
nicotine were excluded; n = 119 
 
Chinese non-alcoholics;  
interviewed for psychiatric 
conditions; family history of 
alcoholism or major psychiatric 
or neurological diseases were 
excluded; n = 76 
 
 
 
59 33 5 56 17 3 1.7 
0.92, 3.7 
1.6 
0.37, 6.91 
1.8 
0.93, 3.46 
14 Matsushita  
2001 
 
 
 
 
Japanese alcoholic subjects with 
antisocial personality; DSM-III-R 
criteria; structure interview for 
family alcohol history; n = 679 
males; mean age 50.5 
 
Japanese non-alcoholics; KAST 
assessment; n = 270; mean age 
50.0 
 
 
8 214 443 13 84 173 4.1 
1.65 , 10.3 
4.2 
1.71, 10.5 
4.0 
1.72, 9.87 
15 Marques  
2006 
European Brazilian alcoholic 
subjects with drug abuse, antisocial 
personality, major depressive 
disorder, suicide attempts and 
ideation and nicotine addiction; 
DSM-III-R criteria; Semi-Structured 
Assessment for the Genetics of 
Alcoholism interview used; males 
n=114 
 
European Brazilian non-
alcoholics; blood donors; 
interviewed for alcohol and 
nicotine abuse; CAGE 
questionnaire used to measure 
exposure to alcohol; n = 218 
 
Antisocial 
Personality 
8 8 4 24 46 24 0.7 
0.28,  1.31 
0.5 
0.13, 1.84 
0.5 
0.18, 1.51 
Major 
depression 
8 17 16 24 36 12 1.4 
0.53, 3.83 
4.0 
1.34, 11.9 
2.0 
0.83,  5.15 
Suicide 
attempt 
13 34 16 56 74 38 1.9 
0.96, 4.10 
1.8 
0.78, 4.20 
1.9 
0.96, 3.83 
16 Mokrovic  
2008 
Croatian type 2 alcoholics with 
PTSD, personality disorder, 
anxiety/depression; DSM-IV criteria; 
n = 59 males; 
mean age 32 years 
 
Croatian non-alcoholic blood 
donors; no personal or family 
history of alcohol dependence 
or psychiatric disorder; n = 
282; mean age 42 years 
 
 
 
26 26 6 102 138 42 1.3 
0.50, 3.41 
1.7 
0.68,  4.53 
1.5 
0.61, 3.75 
17 Pastorelli  
2001 
 
 
 
 
Italian alcoholic subjects; seeking 
treatment or admitted for medical 
reasons; 80% smokers; 27% 
polysubstance abusers; interview; n 
= 60; 45 males, 15 females; 
mean age, 46.4 years 
Italian blood donors matched 
on sex and age; non-alcoholics; 
33% smokers; 0 % 
polysubstance abusers; 
interview; n = 64; 51 males, 13 
females; mean age, 45 years 
 
 
26 25 9 21 34 9 0.7 
0.25, 2.38 
1.2 
0.41, 3.77 
0.9 
0.34, 2.51 
 4 
 
   
18 Samochwiec  
2008 
Polish alcoholic subjects; ICD-10 
criteria; interview; n = 122; 
99 males,23 females; 
mean age 39 years old 
 
 
 
Polish non-alcoholic; 
questionnaires to exclude drug 
and alcohol dependence; 
n = 150; 120 males, 30 
females; mean age 35 years 
old 
 
 
 
45 43 12 41 48 11 0.82 
0.37, 2.05 
0.9 
0.38, 2.17 
0.9 
0.38, 2.16 
19 Preuss  
2001 
 
 
German alcoholic subjects with 
suicide attempts; ICD-10, DSM-IV 
criteria; semi-structured interview; 
n = 163; 131 males, 32 females 
 
 
German non-alcoholic controls; 
psychiatric, mental and 
substance abuse disorders 
excluded; n = 117; 
56 males, 61 females 
With 
suicide 
 
11 30 11 41 58 18 0.8 
0.41, 1.91 
0.4 
0.74, 1.18 
0.6 
0.21, 1.43 
Without 
suicide 
 
40 57 14    1.3 
0.52, 2.96 
1.2 
0.55, 2.84 
1.3 
0.62, 2.65 
 
20 Saiz  
2009 
 
 
 
Spanish alcoholic subjects; 
substance dependence other than 
nicotine excluded; interview; 
EuropASI criteria; n = 165; mean age 
47.8 
 
Spanish non-alcoholic controls; 
interview; n = 420; 
mean age 31.6 
 
 
44 93 27 124 203 93 1.5 
0.94, 2.73 
0.8 
0.45, 1.46 
1.1 
0.72, 1.72 
21 Sander  
1997 
 
 
 
 
 
 
German alcoholic subjects; 
International Classification of 
Disease criteria; interviewed on the 
history of alcohol abuse; n = 315; 
271 males, 44 females; mean age 
42.2 
 
 
German non-alcoholics; blood 
donors and other were 
interviewed for absence of 
addictive disorder or previous 
psychiatric treatment;  
n = 216 
 
 
32 44 27 81 100 35 1.7 
0.98, 3.20 
0.3 
0.0 7, 2.91 
0.9 
0.68, 1.67 
22 Shin  
2009 
Chinese alcoholic subjects; DSM-IV 
criteria; semi structured interview; 
n = 68 males only; mean age 72.5 
 
Chinese non-alcoholics; semi-
structured interview;  
n = 232 males only; mean age 
72.5 
 
 10 26 32 30 77 125 1.2 
0.71, 2.46 
1.3 
0.52, 2.95 
1.1 
0.74, 2.28 
23 Stoltenberg  
2002 
Caucasian biological family (50 
families) alcohol dependents; DSM-
III-R criteria; NOE-FFI personality 
test; n = 31 
 
Caucasian biological family 
non-alcohol dependents; 
n = 13 
 
 
AAL 
 
 
3 10 4 5 6 2 1.1 
0.36, 23.9 
3.3 
0.24, 55.3 
1.8 
0.57,  5.81 
NAAL 4 6 4    1.2 
0.16, 9.89 
2.5 
0.19, 39.5 
1.4 
0.42, 4.67 
24 Thompson  
2000 
Blood samples from volunteers 
from the CAMH; DSM-IV criteria; 
Blood samples from non-
alcoholic volunteers from 
 43 52 36 51 55 19 1.1 
0.62, 2.03 
2.2 
1.07, 4.76 
2.2 
1.20, 4.45 
 5 
 
 
 
 
psychiatric disorders excluded; 
n = 131 
 
CAMH; n = 125 
25 Wang  
2011 
Chinese alcoholic subjects; DSM-IV 
criteria;  major psychiatric disorder 
or substance dependence other 
than alcohol or nicotine excluded;   
n = 113; average age 38.9 
Non-alcoholic controls; 
without  major psychiatric 
disorder or substance 
dependence ; n = 214; average 
age 32.7; 203 male, 11 females 
 
 
 
83 26 9 124 77 13 0.5 
0.29, 0.87 
1.0 
0.37, 2.7 
0.5 
0.36,  0.94 
 
 
CI = confidence interval; ALL = antisocial alcoholic; NAAL = nonalcoholic; ORhet = odds ratio of heterozygotes vs. homozygotes for the major allele; 
ORhom = odds ratio of homozygotes for the minor allele vs. homozygotes for the major allele; ORadd = odds ratio of each increased r-fold for 
heterozygotes and  2r-fold for homozygotes allele 
 
 6 
 
 
 
Table 2: Analysis of effect modification by study characteristics 
Characteristics 
Allele frequency  Recessive model  Dominant model Additive model 
Β (95% CI) P†  Β (95% CI) P†  Β (95% CI) P† Β (95% CI) P† 
Publication year 0.02 (-0.01, 0.05) .12  0.02 (-0.01, 0.06) .21  -0.03 (-0.08, 0.02) .22 -0.06 (-0.25, 0.13) .44 
Gender -0.07 (-0.33, 0.18) .56  -0.09 (-0.39, 0.20) .50  0.07 (-0.40, 0.53) .77 -0.19 (-1.01, 0.62) .57 
Race/ethnicity
††
 -0.06 (-0.32, 0.19) .63  -0.02 (-0.32, 0.27) .87  0.26 (-0.21, 0.73) .43 -0.14 (-1.56, 1.28) .81 
Psychiatric condition -0.26 (-0.58, 0.07) .12  -0.10 (-0.37, 0.16) .41  0.54 (-0.10, 1.18) .09 1.49 (-2.08, 5.05) .33 
Diagnostic criteria           
     ICD-10 0.11 (-0.32, 0.55) .59  0.07 (-0.46, 0.60) .79  -0.32 (-1.13, 0.50) .26 -0.94 (-5.46, 3.58) .62 
     DSM IV 0.36 (-0.03, 0.76) .07  0.33 (-0.14, 0.81) .16  -0.62 (-1.36, 0.12) .10 -1.45 (-5.29, 2.39) .44 
† Based on 1000 Monte Carlo simulations. 
†† 
Race/ethnicity dichotomized in European vs. Non-Europeans 
Analysis for effect modification performed using multivariate meta-regressions with log effect sizes and its standard error as 
outcomes and characteristics as independent variables.   
 
 
 
